D
David Mesher
Researcher at Public Health England
Publications - 62
Citations - 5563
David Mesher is an academic researcher from Public Health England. The author has contributed to research in topics: Population & Vaccination. The author has an hindex of 30, co-authored 59 publications receiving 4859 citations. Previous affiliations of David Mesher include Queen Mary University of London & University of London.
Papers
More filters
Journal ArticleDOI
Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy
George Du Toit,Yitzhak Katz,Peter Sasieni,David Mesher,Soheila J. Maleki,Helen R. Fisher,Adam T. Fox,Victor Turcanu,Tal Amir,Galia Zadik-Mnuhin,Adi Cohen,Irit Livne,Gideon Lack +12 more
TL;DR: It is demonstrated that Jewish children in the UK have a prevalence of PA that is 10-fold higher than that ofJewish children in Israel, and this difference is not accounted for by differences in atopy, social class, genetic background, or peanut allergenicity.
Journal ArticleDOI
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.
Jack Cuzick,Gregory P. Swanson,Gabrielle Fisher,Arthur R. Brothman,Daniel M. Berney,Julia Reid,David Mesher,V. O. Speights,Elzbieta Stankiewicz,Christopher S. Foster,Henrik Møller,Peter T. Scardino,Jorja D Warren,Jimmy Park,Adib Younus,Darl D. Flake,Susanne Wagner,Alexander Gutin,Jerry S. Lanchbury,Steven Stone +19 more
TL;DR: There is strong evidence that the CCP score is a robust prognostic marker, which, after additional validation, could have an essential role in determining the appropriate treatment for patients with prostate cancer.
Journal ArticleDOI
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes : updated systematic review and meta-analysis
Mélanie Drolet,Élodie Bénard,Norma Pérez,Marc Brisson,Marc Brisson,Hammad Ali,Marie-Claude Boily,Vincenzo Baldo,Paul Brassard,Julia M.L. Brotherton,Denton Callander,Marta Checchi,Eric P F Chow,Silvia Cocchio,Tina Dalianis,Shelley L Deeks,Christian Dehlendorff,Basil Donovan,Christopher K Fairley,Elaine W. Flagg,Julia W Gargano,Suzanne M. Garland,Nathalie Grün,Bo T. Hansen,Christopher Harrison,Eva Herweijer,Teresa M. Imburgia,Anne M Johnson,Jessica A. Kahn,Kimberley Kavanagh,Susanne K. Kjaer,Erich V. Kliewer,Bette Liu,Dorothy A Machalek,Lauri E. Markowitz,David Mesher,Christian Munk,Linda M. Niccolai,Mari Nygård,Gina Ogilvie,Jeannie Oliphant,Kevin G.J. Pollock,Maria Jesús Purriños-Hermida,Megan Smith,Marc Steben,Anna Söderlund-Strand,Pam Sonnenberg,Pär Sparén,Clare Tanton,Cosette M. Wheeler,Petra J Woestenberg,Bo Nancy Yu +51 more
TL;DR: The results show compelling evidence of the substantial impact of HPV vaccination programmes on HPV infections and CIN2+ among girls and women, and on anogenital warts diagnoses among girls, women, boys, and men.
Journal ArticleDOI
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
Mélanie Drolet,Élodie Bénard,Marie-Claude Boily,Marie-Claude Boily,Hammad Ali,Louise Baandrup,Heidi M. Bauer,Simon Beddows,Jacques Brisson,Julia M.L. Brotherton,Teresa Cummings,Basil Donovan,Christopher K Fairley,Elaine W. Flagg,Anne M Johnson,Jessica A. Kahn,Kimberley Kavanagh,Susanne K. Kjaer,Erich V. Kliewer,Philippe Lemieux-Mellouki,Lauri E. Markowitz,Aminata Mboup,David Mesher,Linda M. Niccolai,Jeannie Oliphant,Kevin G.J. Pollock,Kate Soldan,Pam Sonnenberg,Sepehr N. Tabrizi,Sepehr N. Tabrizi,Clare Tanton,Marc Brisson,Marc Brisson +32 more
TL;DR: The results are promising for the long-term population-level effects of HPV vaccination programmes, however, continued monitoring is essential to identify any signals of potential waning efficacy or type-replacement.
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
Mélanie Drolet,Élodie Bénard,Marie-Claude Boily,Hammad Ali,Louise Baandrup,Simon Beddows,Jacques Brisson,Julia M.L. Brotherton,Teresa Cummings,Basil Donovan,Christopher K Fairley,Elaine W. Flagg,Anne M Johnson,Jessica A. Kahn,Kimberley Kavanagh,Susanne K. Kjaer,Erich V. Kliewer,Philippe Lemieux-Mellouki,Lauri E. Markowitz,Aminata Mboup,David Mesher,Linda M. Niccolai,Jeannie Oliphant,Kevin G.J. Pollock,Kate Soldan,Pam Sonnenberg,Sepehr N. Tabrizi,Clare Tanton,Marc Brisson +28 more
TL;DR: A systematic review and meta-analysis to assess the population-level consequences and herd effects after female HPV vaccination programs, to verify whether or not the high efficacy reported in randomised controlled clinical trials are materialising in real-world situations is materializing in realworld situations.